Accessibility Menu
Organon & Co. logo

Organon & Co.

(NYSE) OGN

Current Price$13.45
Market Cap$3.53B
Since IPO (2021)-50%
5 Year-46%
1 Year+35%
1 Month+0%

Organon & Co. Financials at a Glance

Market Cap

$3.53B

Revenue (TTM)

$6.16B

Net Income (TTM)

$246.00M

EPS (TTM)

$0.94

P/E Ratio

14.32

Dividend

$0.08

Beta (Volatility)

0.81 (Low)

Price

$13.45

Volume

2,164,231

Open

$13.43

Previous Close

$13.44

Daily Range

$13.42 - $13.46

52-Week Range

$5.69 - $13.49

Estimated Earnings Date

Aug 11, 2026

About Organon & Co.

Industry

Pharmaceuticals

Employees

10,000

CEO

Joseph T. Morrissey, Jr., MBA

Headquarters

Jersey City, NJ 07302, US

OGN Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

19%

Net Income Margin

4%

Return on Equity

34%

Return on Capital

11%

Return on Assets

2%

Earnings Yield

6.98%

Dividend Yield

0.60%

Payout Ratio

8.94%

Stock Overview

Market Cap

$3.53B

Shares Outstanding

262.61M

Volume

2.16M

Avg. Volume

8.52M

Financials (TTM)

Gross Profit

$3.36B

Operating Income

$1.29B

EBITDA

$1.28B

Operating Cash Flow

$700.00M

Capital Expenditure

-$162.00M

Free Cash Flow

$538.00M

Cash & ST Invst.

$574.00M

Total Debt

$8.80B

Organon & Co. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.46B

-3.5%

Gross Profit

$783.00M

-6.9%

Gross Margin

53.63%

N/A

Market Cap

$3.53B

N/A

Market Cap/Employee

$352.95K

N/A

Employees

10,000

N/A

Net Income

$146.00M

+67.8%

EBITDA

$409.00M

+25.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.12B

+104.0%

Total Debt

$8.57B

-4.3%

Accounts Receivable

$1.39B

-5.6%

Inventory

$1.37B

+0.8%

Long Term Debt

$8.55B

-4.3%

Short Term Debt

$16.00M

-20.0%

Return on Assets

1.89%

N/A

Return on Invested Capital

11.29%

N/A

Free Cash Flow

$188.00M

+954.5%

Operating Cash Flow

$225.00M

+200.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GRDNGuardian Pharmacy Services, Inc.
$42.88-0.49%
AVDLAvadel Pharmaceuticals plc
$21.64+0.00%
SEMSelect Medical Holdings Corporation
$16.65-0.06%
AUPHAurinia Pharmaceuticals Inc.
$16.00+1.14%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.46+0.03%
NOKNokia
$14.82+0.00%
PAYOPayoneer Global
$7.03+0.04%
SOFISoFi Technologies
$17.13+0.03%

Questions About OGN

What is the current price of Organon & Co.?

Organon & Co. is trading at $13.44 per share.

What is the 52-week range for Organon & Co.?

Over the past 52 weeks, Organon & Co. has traded between $5.69 and $13.49.

How much debt does Organon & Co. have?

As of the most recent reporting period, Organon & Co. reported total debt of $8.57B.

How much cash does Organon & Co. have on hand?

Organon & Co. reported $1.12B in cash and cash equivalents in its most recent financial results.

What is Organon & Co.’s dividend yield?

Organon & Co. currently has a dividend yield of 0.60%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.